Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    cambridge's bluebird bio licenses delivery tech to novartis, gsk .
    . . .

    the uk may have to pay a multimillion-euro fine for air pollution .

  • .